My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.660 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Recursion Pharmaceuticals (NASDAQ: RXRX) Forms Powerful Partnership with NVIDIA (NASDAQ: NVDA)

July 12, 2023

A $50 Million Investment to Boost AI Capabilities in Drug Discovery Recursion Pharmaceuticals (NASDAQ: RXRX), a trailblazer in TechBio that

Via Spotlight Growth

Topics Artificial Intelligence

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 12, 2023

Via Benzinga

Stocks Extend Rally On Cooler-Than-Expected CPI Reading ↗

July 12, 2023

The S&P 500 Index and Nasdaq Composite sport solid midday leads, as investors hope the data may push the Federal Reserve away from more interest rate hikes.

Via Talk Markets

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

Why Shares of Recursion Pharmaceuticals Are Skyrocketing Wednesday ↗

July 12, 2023

The company just received a $50 million investment from Nvidia.

Via The Motley Fool

Why Recursion Pharmaceuticals Stock is Skyrocketing Today? ↗

July 12, 2023

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares are trading higher after the company announced a $50 million investment by NVIDIA Corporation (NASDAQ: NVDA), executed as a private

Via Benzinga

S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected ↗

July 12, 2023

U.S. stocks traded higher midway through trading, with the S&P 500 gaining 1% on Wednesday. The Dow traded up 0.84% to 34,550.13 while the NASDAQ rose 1.32% to 13,941.87. The S&P 500, also rose,...

Via Benzinga

Recursion Catapults 70% On Nvidia Investment For AI In Drug Development ↗

July 12, 2023

Nvidia is hoping to help this company accelerate its efforts in AI-related drug development.

Via Investor's Business Daily

InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday ↗

July 12, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Expert Ratings for Recursion Pharmaceuticals ↗

May 09, 2023

Via Benzinga

Recursion Pharmaceuticals's Return On Capital Employed Overview ↗

March 03, 2023

Via Benzinga

Nasdaq Rises Over 1%; US Inflation Rate Falls In June ↗

July 12, 2023

U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.78% to 34,527.32 while the NASDAQ rose 1.18%...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 12, 2023

Via Benzinga

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery

July 12, 2023

Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster

From Recursion Pharmaceuticals

Via GlobeNewswire

Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗

July 10, 2023

U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.

Via Benzinga

Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom ↗

July 08, 2023

AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.

Via InvestorPlace

Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now ↗

June 29, 2023

With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend.

Via InvestorPlace

Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem

June 26, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled

June 13, 2023

Recursion's small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial for cerebral cavernous malformation (CCM). CCM is a devastating...

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

June 01, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion Pharmaceuticals Is Going Big on AI. Here's Why It Could Be Worth Buying ↗

May 29, 2023

It's competing in a soon-to-be hotly contested space.

Via The Motley Fool

Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 23, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 22, 2023

Via Benzinga

Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 22, 2023

Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.

Via Benzinga

Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer

May 16, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results

May 08, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities

May 08, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

May 02, 2023

From Recursion Pharmaceuticals

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

April 07, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023 ↗

March 16, 2023

Via Benzinga

< Previous 1 2

...

15 16 17 18 19 20 21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.